Squarepoint’s Strongbridge Biopharma SBBP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
– Sell
-24,493
Closed -$60K – 3840
2020
Q4
$60K Buy
24,493
+11,713
+92% +$28.2K ﹤0.01% 2790
2020
Q3
$27K Buy
+12,780
New +$43.1K ﹤0.01% 2408
2018
Q4
– Sell
-34,124
Closed -$166K – 2358
2018
Q3
$166K Sell
34,124
-22,361
-40% -$114K ﹤0.01% 1810
2018
Q2
$339K Buy
+56,485
New +$413K ﹤0.01% 1331

Other funds holding SBBP

Squarepoint's SBBP Position: Q1 2021 in Review

Squarepoint sold out of Strongbridge Biopharma (SBBP) in Q1 2021, closing a stake of 24,493 shares — an estimated $60K sold.

Squarepoint first reported a position in SBBP in Q2 2018 and held it in 4 quarters. The position peaked at $339K in Q2 2018. 74 funds tracked by Wall St. Rank hold SBBP as of Q1 2021.

  • Squarepoint reported no remaining Strongbridge Biopharma position as of Q1 2021 after selling out during the quarter.
  • Squarepoint sold 24,493 Strongbridge Biopharma shares in Q1 2021, an estimated $60K.
  • Squarepoint first reported a position in Strongbridge Biopharma in Q2 2018 and held it in 4 quarters.
  • Squarepoint's Strongbridge Biopharma position peaked at $339K in Q2 2018.
  • 74 funds tracked by Wall St. Rank held Strongbridge Biopharma as of Q1 2021.

Based on Squarepoint's 13F filing for Q1 2021, filed 17 May 2021.